Literature DB >> 305284

Angioimmunoblastic lymphadenopathy: an ultrastructural and immunologic study with review of the literature.

R S Neiman, P Dervan, C Haudenschild, R Jaffe.   

Abstract

Six cases of angioimmunoblastic lymphadenopathy (AIBL) are presented, detailed ultrastructural and immunohistologic studies of several involved organs are described, and the literature is reviewed. The features of the lesion are of normal immune reactive cells containing polyclonal cytoplasmic immunoglobulin. Large numbers of dying and degenerating cells result in accumulations of cell debris, corresponding to the characteristic interstitial material seen by light microscopy. Our studies confirm that the vascular changes are unique to lymph nodes, appear confined to postcapillary venules, and consist of endothelial cell hypertrophy and expansion of the vessel wall by basement membrane-like material, cellular debris and collagen fibers. No deposits of amyloid or antigen-antibody complexes were noted by ultrastructural or immunologic techniques. Our data reveal morphologic and laboratory features of a hyperimmune state but with paradoxical cutaneous anergy and decrease in blood (T) lymphocytes. We postulate that AIBL is an abnormal, but non-neoplastic immune reaction related to the autoimmune disorders, resulting from a loss of suppressor T cells with hyperfunction of the B lymphocyte system.

Entities:  

Mesh:

Year:  1978        PMID: 305284     DOI: 10.1002/1097-0142(197802)41:2<507::aid-cncr2820410218>3.0.co;2-d

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  14 in total

1.  Haematological features of angioimmunoblastic lymphadenopathy with dysproteinaemia.

Authors:  R L Brearley; J Chapman; M H Cullen; M A Horton; A G Stansfeld; A H Waters
Journal:  J Clin Pathol       Date:  1979-04       Impact factor: 3.411

2.  The blood microvasculature in T-cell lymphomas. A morphological, ultrastructural and immunohistochemical study.

Authors:  C Kittas; M L Hansmann; B Borisch; A C Feller; K Lennert
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

3.  Evidence for monoclonal T lymphocyte proliferation in angioimmunoblastic lymphadenopathy.

Authors:  N T O'Connor; J A Crick; J S Wainscoat; K C Gatter; H Stein; B Falini; D Y Mason
Journal:  J Clin Pathol       Date:  1986-11       Impact factor: 3.411

4.  Angioimmunoblastic lymphadenopathy. Fine structure of the lymph nodes by correction of light and electron microscopical findings.

Authors:  U Schnaidt; J Thiele; A Georgii
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980

5.  Angioimmunoblastic lymphadenopathy. Histopathology of bone marrow involvement.

Authors:  U Schnaidt; K F Vykoupil; J Thiele; A Georgii
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980

6.  [Disease-specific renal failure in angioimmunoblastic lymphadenopathy - remission by high dose prednisolone. A case report (author's transl)].

Authors:  E Platzer; R von Roemeling; B Kaduk; U Meinl
Journal:  Klin Wochenschr       Date:  1981-05-15

7.  Rapidly fatal respiratory failure and angioimmunoblastic lymphadenopathy: possible contributions of immunoblastic leukaemia, chemotherapy, and multiple antibodies directed against mature blood cells.

Authors:  P M Trenchard; J A Whittaker; J Gough; H Parry
Journal:  J Clin Pathol       Date:  1981-05       Impact factor: 3.411

8.  Genetic changes in atypical hyperplasia and lymphoma with angioimmunoblastic lymphadenopathy and dysproteinaemia in the same patients.

Authors:  K Ohshima; M Kikuchi; M Hashimoto; M Kozuru; N Uike; S Kobari; Y Masuda; Y Sumiyoshi; S Yoneda; M Takeshita
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

9.  Histological, immunohistological and autopsy findings in lymphogranulomatosis X (including angio-immunoblastic lymphadenopathy).

Authors:  H Knecht; E W Schwarze; K Lennert
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

10.  Immunological studies in angioimmunoblastic lymphadenopathy.

Authors:  A Skibin; T Yeremiyahu; A Keynan; M R Quastel
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.